Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 89

1.

Identification of an Immunogenic Broadly Inhibitory Surface Epitope of the Plasmodium vivax Duffy Binding Protein Ligand Domain.

George MT, Schloegel JL, Ntumngia FB, Barnes SJ, King CL, Casey JL, Foley M, Adams JH.

mSphere. 2019 May 15;4(3). pii: e00194-19. doi: 10.1128/mSphere.00194-19.

2.

Restoration of HCV-Specific Immune Responses with Antiviral Therapy: A Case for DAA Treatment in Acute HCV Infection.

Casey JL, Feld JJ, MacParland SA.

Cells. 2019 Apr 5;8(4). pii: E317. doi: 10.3390/cells8040317. Review.

3.

Hepatitis Delta Antigen Regulates mRNA and Antigenome RNA Levels during Hepatitis Delta Virus Replication.

Harichandran K, Shen Y, Stephenson Tsoris S, Lee SC, Casey JL.

J Virol. 2019 Apr 3;93(8). pii: e01989-18. doi: 10.1128/JVI.01989-18. Print 2019 Apr 15.

4.

Early Bubble Continuous Positive Airway Pressure: Investigating Interprofessional Best Practices for the NICU Team.

Casey JL, Newberry D, Jnah A.

Neonatal Netw. 2016;35(3):125-34. doi: 10.1891/0730-0832.35.3.125.

PMID:
27194606
5.

i-bodies, Human Single Domain Antibodies That Antagonize Chemokine Receptor CXCR4.

Griffiths K, Dolezal O, Cao B, Nilsson SK, See HB, Pfleger KD, Roche M, Gorry PR, Pow A, Viduka K, Lim K, Lu BG, Chang DH, Murray-Rust T, Kvansakul M, Perugini MA, Dogovski C, Doerflinger M, Zhang Y, Parisi K, Casey JL, Nuttall SD, Foley M.

J Biol Chem. 2016 Jun 10;291(24):12641-57. doi: 10.1074/jbc.M116.721050. Epub 2016 Apr 1.

6.

Targeting of Fn14 Prevents Cancer-Induced Cachexia and Prolongs Survival.

Johnston AJ, Murphy KT, Jenkinson L, Laine D, Emmrich K, Faou P, Weston R, Jayatilleke KM, Schloegel J, Talbo G, Casey JL, Levina V, Wong WW, Dillon H, Sahay T, Hoogenraad J, Anderton H, Hall C, Schneider P, Tanzer M, Foley M, Scott AM, Gregorevic P, Liu SY, Burkly LC, Lynch GS, Silke J, Hoogenraad NJ.

Cell. 2015 Sep 10;162(6):1365-78. doi: 10.1016/j.cell.2015.08.031.

7.

RNA helicase A activity is inhibited by oncogenic transcription factor EWS-FLI1.

Erkizan HV, Schneider JA, Sajwan K, Graham GT, Griffin B, Chasovskikh S, Youbi SE, Kallarakal A, Chruszcz M, Padmanabhan R, Casey JL, Üren A, Toretsky JA.

Nucleic Acids Res. 2015 Jan;43(2):1069-80. doi: 10.1093/nar/gku1328. Epub 2015 Jan 6.

8.

MicroRNA-mediated transformation by the Kaposi's sarcoma-associated herpesvirus Kaposin locus.

Forte E, Raja AN, Shamulailatpam P, Manzano M, Schipma MJ, Casey JL, Gottwein E.

J Virol. 2015 Feb;89(4):2333-41. doi: 10.1128/JVI.03317-14. Epub 2014 Dec 10.

9.

Hepatitis delta antigen requires a flexible quasi-double-stranded RNA structure to bind and condense hepatitis delta virus RNA in a ribonucleoprotein complex.

Griffin BL, Chasovskikh S, Dritschilo A, Casey JL.

J Virol. 2014 Jul;88(13):7402-11. doi: 10.1128/JVI.00443-14. Epub 2014 Apr 16.

10.

Arginine-rich motifs are not required for hepatitis delta virus RNA binding activity of the hepatitis delta antigen.

Daigh LH, Griffin BL, Soroush A, Mamedov MR, Casey JL.

J Virol. 2013 Aug;87(15):8665-74. doi: 10.1128/JVI.00929-13. Epub 2013 Jun 5.

11.

Fine specificity of Plasmodium vivax Duffy binding protein binding engagement of the Duffy antigen on human erythrocytes.

Siddiqui AA, Xainli J, Schloegel J, Carias L, Ntumngia F, Shoham M, Casey JL, Foley M, Adams JH, King CL.

Infect Immun. 2012 Aug;80(8):2920-8. doi: 10.1128/IAI.00206-12. Epub 2012 May 21. Retraction in: Infect Immun. 2015 Jun;83(6):2593.

12.

Control of ADAR1 editing of hepatitis delta virus RNAs.

Casey JL.

Curr Top Microbiol Immunol. 2012;353:123-43. doi: 10.1007/82_2011_146. Review.

13.

Peptides specific for Mycobacterium avium subspecies paratuberculosis infection: diagnostic potential.

Casey JL, Sanalla AM, Tamvakis D, Thalmann C, Carroll EL, Parisi K, Coley AM, Stewart DJ, Vaughan JA, Michalski WP, Luke R, Foley M.

Protein Eng Des Sel. 2011 Aug;24(8):589-96. doi: 10.1093/protein/gzr026. Epub 2011 Jun 13.

PMID:
21669956
14.

RNA editing and its control in hepatitis delta virus replication.

Chen R, Linnstaedt SD, Casey JL.

Viruses. 2010 Jan;2(1):131-46. doi: 10.3390/v2010131. Epub 2010 Jan 12.

15.

Multimerization of hepatitis delta antigen is a critical determinant of RNA binding specificity.

Lin BC, Defenbaugh DA, Casey JL.

J Virol. 2010 Feb;84(3):1406-13. doi: 10.1128/JVI.01723-09. Epub 2009 Nov 18.

16.

The fraction of RNA that folds into the correct branched secondary structure determines hepatitis delta virus type 3 RNA editing levels.

Linnstaedt SD, Kasprzak WK, Shapiro BA, Casey JL.

RNA. 2009 Jun;15(6):1177-87. doi: 10.1261/rna.1504009. Epub 2009 Apr 21.

17.

Hepatitis delta antigen requires a minimum length of the hepatitis delta virus unbranched rod RNA structure for binding.

Defenbaugh DA, Johnson M, Chen R, Zheng YY, Casey JL.

J Virol. 2009 May;83(9):4548-56. doi: 10.1128/JVI.02467-08. Epub 2009 Feb 25.

18.

Rapid optimization of a peptide inhibitor of malaria parasite invasion by comprehensive N-methyl scanning.

Harris KS, Casey JL, Coley AM, Karas JA, Sabo JK, Tan YY, Dolezal O, Norton RS, Hughes AB, Scanlon D, Foley M.

J Biol Chem. 2009 Apr 3;284(14):9361-71. doi: 10.1074/jbc.M808762200. Epub 2009 Jan 21.

19.

Isolation of antibodies specific to a single conformation-dependant antigenic determinant on the EG95 hydatid vaccine.

Read AJ, Casey JL, Coley AM, Foley M, Gauci CG, Jackson DC, Lightowlers MW.

Vaccine. 2009 Feb 11;27(7):1024-31. doi: 10.1016/j.vaccine.2008.11.096. Epub 2008 Dec 16.

20.

Peptide mimics selected from immune sera using phage display technology can replace native antigens in the diagnosis of Epstein-Barr virus infection.

Casey JL, Coley AM, Parisi K, Foley M.

Protein Eng Des Sel. 2009 Feb;22(2):85-91. doi: 10.1093/protein/gzn076. Epub 2008 Dec 10.

21.

Phage display of peptides in ligand selection for use in affinity chromatography.

Casey JL, Coley AM, Foley M.

Methods Mol Biol. 2008;421:111-24.

PMID:
18826051
22.

Gene symbol: MEN1. Disease: Multiple endocrine neoplasia 1.

Dasouki M, Casey JL.

Hum Genet. 2008 Jun;123(5):548-9. No abstract available.

PMID:
20960638
23.

Display of a peptide mimotope on a crystalline bacterial cell surface layer (S-layer) lattice for diagnosis of Epstein-Barr virus infection.

Tschiggerl H, Casey JL, Parisi K, Foley M, Sleytr UB.

Bioconjug Chem. 2008 Apr;19(4):860-5. doi: 10.1021/bc7003523. Epub 2008 Apr 1.

PMID:
18376854
24.

RNA editing of the human herpesvirus 8 kaposin transcript eliminates its transforming activity and is induced during lytic replication.

Gandy SZ, Linnstaedt SD, Muralidhar S, Cashman KA, Rosenthal LJ, Casey JL.

J Virol. 2007 Dec;81(24):13544-51. Epub 2007 Oct 3.

25.

Continuous nonfluoroscopic localization of the esophagus during radiofrequency catheter ablation of atrial fibrillation.

Sherzer AI, Feigenblum DY, Kulkarni S, Pina JW, Casey JL, Salka KA, Simons GR.

J Cardiovasc Electrophysiol. 2007 Feb;18(2):157-60. Erratum in: J Cardiovasc Electrophysiol. 2007 Apr;18(4):458.

PMID:
17338764
26.

Mimotopes of apical membrane antigen 1: Structures of phage-derived peptides recognized by the inhibitory monoclonal antibody 4G2dc1 and design of a more active analogue.

Sabo JK, Keizer DW, Feng ZP, Casey JL, Parisi K, Coley AM, Foley M, Norton RS.

Infect Immun. 2007 Jan;75(1):61-73. Epub 2006 Oct 23.

27.

The woodchuck model of HDV infection.

Casey JL, Gerin JL.

Curr Top Microbiol Immunol. 2006;307:211-25. Review.

PMID:
16903228
28.

RNA editing in hepatitis delta virus.

Casey JL.

Curr Top Microbiol Immunol. 2006;307:67-89. Review.

PMID:
16903221
29.

The role of a metastable RNA secondary structure in hepatitis delta virus genotype III RNA editing.

Linnstaedt SD, Kasprzak WK, Shapiro BA, Casey JL.

RNA. 2006 Aug;12(8):1521-33. Epub 2006 Jun 21.

30.
31.

The most polymorphic residue on Plasmodium falciparum apical membrane antigen 1 determines binding of an invasion-inhibitory antibody.

Coley AM, Parisi K, Masciantonio R, Hoeck J, Casey JL, Murphy VJ, Harris KS, Batchelor AH, Anders RF, Foley M.

Infect Immun. 2006 May;74(5):2628-36.

32.

Peptide mimotopes selected from a random peptide library for diagnosis of Epstein-Barr virus infection.

Casey JL, Coley AM, Street G, Parisi K, Devine PL, Foley M.

J Clin Microbiol. 2006 Mar;44(3):764-71.

33.

Binding hot spot for invasion inhibitory molecules on Plasmodium falciparum apical membrane antigen 1.

Harris KS, Casey JL, Coley AM, Masciantonio R, Sabo JK, Keizer DW, Lee EF, McMahon A, Norton RS, Anders RF, Foley M.

Infect Immun. 2005 Oct;73(10):6981-9.

35.

Selection and affinity maturation of IgNAR variable domains targeting Plasmodium falciparum AMA1.

Nuttall SD, Humberstone KS, Krishnan UV, Carmichael JA, Doughty L, Hattarki M, Coley AM, Casey JL, Anders RF, Foley M, Irving RA, Hudson PJ.

Proteins. 2004 Apr 1;55(1):187-97.

PMID:
14997552
36.

Antibodies to malaria peptide mimics inhibit Plasmodium falciparum invasion of erythrocytes.

Casey JL, Coley AM, Anders RF, Murphy VJ, Humberstone KS, Thomas AW, Foley M.

Infect Immun. 2004 Feb;72(2):1126-34.

37.

In vivo antiviral efficacy of prenylation inhibitors against hepatitis delta virus.

Bordier BB, Ohkanda J, Liu P, Lee SY, Salazar FH, Marion PL, Ohashi K, Meuse L, Kay MA, Casey JL, Sebti SM, Hamilton AD, Glenn JS.

J Clin Invest. 2003 Aug;112(3):407-14.

38.

Cambridge Healthtech Institute's 4th Annual Recombinant Antibodies Conference.

Casey JL, Coley AM.

Expert Opin Biol Ther. 2003 Aug;3(5):859-62.

PMID:
12880385
39.
42.

A prenylation inhibitor prevents production of infectious hepatitis delta virus particles.

Bordier BB, Marion PL, Ohashi K, Kay MA, Greenberg HB, Casey JL, Glenn JS.

J Virol. 2002 Oct;76(20):10465-72.

44.

Tumour targeting of humanised cross-linked divalent-Fab' antibody fragments: a clinical phase I/II study.

Casey JL, Napier MP, King DJ, Pedley RB, Chaplin LC, Weir N, Skelton L, Green AJ, Hope-Stone LD, Yarranton GT, Begent RH.

Br J Cancer. 2002 May 6;86(9):1401-10.

46.

Rapid and precise epitope mapping of monoclonal antibodies against Plasmodium falciparum AMA1 by combined phage display of fragments and random peptides.

Coley AM, Campanale NV, Casey JL, Hodder AN, Crewther PE, Anders RF, Tilley LM, Foley M.

Protein Eng. 2001 Sep;14(9):691-8.

PMID:
11707616
47.

Characterization of hepatitis D virus genotype III among Yucpa Indians in Venezuela.

Nakano T, Shapiro CN, Hadler SC, Casey JL, Mizokami M, Orito E, Robertson BH.

J Gen Virol. 2001 Sep;82(Pt 9):2183-9.

PMID:
11514728
48.

An outbreak of fulminant hepatitis delta in the Waorani, an indigenous people of the Amazon basin of Ecuador.

Manock SR, Kelley PM, Hyams KC, Douce R, Smalligan RD, Watts DM, Sharp TW, Casey JL, Gerin JL, Engle R, Alava-Alprecht A, Martínez CM, Bravo NB, Guevara AG, Russell KL, Mendoza W, Vimos C.

Am J Trop Med Hyg. 2000 Sep-Oct;63(3-4):209-13.

PMID:
11388517
50.

Discovery, purification, and characterization of a temperate transducing bacteriophage for Bordetella avium.

Shelton CB, Crosslin DR, Casey JL, Ng S, Temple LM, Orndorff PE.

J Bacteriol. 2000 Nov;182(21):6130-6.

Supplemental Content

Loading ...
Support Center